WHO director-general candidates 2026
The Race to Run Global Health: Five Candidates, One Wounded WHO, and the Fight for Tedros's Job
Five people want the hardest job in global health. The WHO director-general candidates for 2026 are now official: nominations closed overnight on September 24–25, and the agency's own website confirms five contenders to replace Tedros Adhanom Ghebreyesus when his term ends in August 2027 — Qatar's Hanan Mohammed Al-Kuwari, Saudi Arabia's Hanan Balkhy, Belgium's Hans Kluge, Spain's Maria Neira, and Indonesia's Budi Gunadi Sadikin. A candidates' forum follows in November; the Executive Board will shortlist up to three in January 2027; the 194 member states elect at the World Health Assembly next May.
Whoever wins this race decides how the world meets the next pandemic. That is not rhetoric. The WHO director-general controls the agency's emergency declarations, its pandemic-treaty negotiations, and the moral authority that moves 194 member states. This is the most consequential leadership vote in the agency's modern history because the institution itself is on the table: Washington ordered its exit in 2025 (effective March 2026), with President Trump accusing the WHO of mishandling COVID — a claim the agency denies — and the financial fallout has been brutal. Nearly a quarter of WHO's staff, more than 2,300 posts, has been cut since early 2025. Some $260 million in unpaid American dues still holes the budget. The November forum, the January shortlist, and the May election are not procedural theater; they are a referendum on whether the WHO survives as a credible global institution or devolves into a geopolitical trophy passed between donor blocs.
The Tedros era and how we got here
Tedros Adhanom Ghebreyesus took office in 2017, the first African to lead the agency. His tenure was defined by the COVID-19 pandemic — the emergency declarations, the fraught relationship with Beijing over early outbreak data, the vaccine-equity campaign that fell short — and by Ebola and mpox responses. The American rupture came in 2025, when the Trump administration ordered withdrawal, reviving the COVID-mishandling accusation. Whatever the merits of that charge, the money was real: the US was the top donor, and its departure triggered two years of financial turmoil that hollowed out programs and forced the deepest staff cuts in the agency's history. The next director-general inherits not a functioning machine but a rebuilding project.
The five WHO director-general candidates
Hanan Mohammed Al-Kuwari (Qatar)
The former health minister carries the Gulf's money-diplomacy playbook into Geneva. Qatar has spent a decade buying soft power — the World Cup, Al Jazeera, mediation portfolios — and global health is the next frontier. Strength: access to capital the WHO desperately needs. Weakness: critics will call it a purchase, not an election.
Hanan Balkhy (Saudi Arabia)
A physician who heads the WHO's Eastern Mediterranean regional office — the insider's insider. Strength: she knows the institution's machinery and would offer continuity. Weakness: continuity is exactly what reformers say the agency cannot afford, and Riyadh's regional rivalries travel with her.
Hans Kluge (Belgium)
WHO Regional Director for Europe since February 2020, he declared his candidacy on August 21, 2026, and took special leave. His résumé is the most field-hardened in the race: Belgian family doctor, Médecins Sans Frontières missions in Liberia and Somalia, tuberculosis programs in Siberian prisons and across the former Soviet Union, WHO posts in the Russian Federation, Myanmar, North Korea, and Thailand. He steered Europe's COVID and mpox responses. Strength: unmatched operational credibility. Weakness: Europe already holds the job's institutional memory; some member states want a clean break from the old guard.
Maria Neira (Spain)
Physician and epidemiologist, former WHO director, the civil-society favorite with a climate-health agenda. Madrid nominated her late, after weeks of deliberation — which tells you how seriously Spain now takes this. Strength: the reformist banner and the environmental-health brief nobody else owns. Weakness: the late start and a thinner political machine behind her.
Budi Gunadi Sadikin (Indonesia)
The sitting health minister of the world's fourth-most-populous country. Strength: the Global South representation argument, and Indonesia's G20 weight. Weakness: active ministers struggle to campaign full-time, and Jakarta's diplomatic reach is narrower than Doha's or Brussels'.
Who benefits, who loses
The winners of a Gulf victory are obvious — Doha and Riyadh would convert financial leverage into institutional control of global health. A Kluge or Neira win keeps the multilateralist flame lit in Europe, which has defended the WHO loudest since Washington walked out. A Budi win would be the Global South's loudest statement yet that the old donor-run order is finished. And China, now the agency's biggest funder with a seat on the Executive Board that shortlists the finalists, benefits quietly no matter who wins — Beijing's pick matters more than any campaign speech. The losers: the United States, absent from the room with no vote to trade; and the reformers, if an insider like Balkhy wins and the agency's culture survives untouched. Critics of each frontrunner make the same underlying charge — that this election is about who pays for the WHO, not who can run it.
What the numbers say
Put the race in context. 194 member states will vote in May 2027. The shortlist of up to three comes from the 34-member Executive Board in January. The budget hole is roughly $260 million in unpaid US dues alone, against an agency that just shed more than 2,300 jobs — nearly one in four. Compare 2017: the race that brought Tedros in was a contest of personalities; this one is a contest of survival. The November candidates' forum is where the money questions get asked in public for the first time.
What happens next: three scenarios
Scenario one, insider continuity (Balkhy or Kluge): calm, competent, donor-friendly — and a missed chance at structural reform. Scenario two, the Gulf-Asia reset (Al-Kuwari or Budi): funding pivots to Doha, Riyadh, Jakarta, and Beijing; the WHO's center of gravity shifts east and south. Scenario three, the reformist pivot (Neira): climate-health moves to the core of the agency's mandate, with civil society as her base. My projection: the money decides. An agency that just fired a quarter of its staff does not elect a purist; it elects whoever can refill the coffers. That favors Al-Kuwari or Balkhy — the Gulf candidates — with Kluge as the compromise the Europeans will push hardest for in the January shortlist.
Conclusion
Strip away the campaign language and this race is about one question: is global health still a shared project, or has it fractured into donor blocs? The five names on the ballot are competent; the institution they want to lead is not yet saved. Whoever wins in May 2027 will be judged not by their biography but by whether the next pandemic finds a WHO that can act — or one still passing the hat.